Total Payments
$21,882
2024 Payments
$3,998
Companies
79
Transactions
928
Medicare Patients
7,527
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$16,984 (77.6%)
Consulting$3,168 (14.5%)
Other$880.93 (4.0%)
Education$849.07 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,984 | 898 | 77.6% |
| Consulting Fee | $3,168 | 2 | 14.5% |
| Long term medical supply or device loan | $880.93 | 9 | 4.0% |
| Education | $849.07 | 19 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,819 | 49 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,376 | 88 | $0 (2024) |
| Seagen Inc. | $1,750 | 29 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,344 | 70 | $0 (2024) |
| PFIZER INC. | $922.04 | 61 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $900.48 | 54 | $0 (2024) |
| Celgene Corporation | $760.59 | 39 | $0 (2024) |
| Janssen Biotech, Inc. | $696.46 | 30 | $0 (2024) |
| Incyte Corporation | $663.77 | 34 | $0 (2024) |
| Daiichi Sankyo Inc. | $660.48 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,998 | 157 | Novartis Pharmaceuticals Corporation ($1,185) |
| 2023 | $4,470 | 121 | AstraZeneca Pharmaceuticals LP ($2,033) |
| 2022 | $2,450 | 122 | Incyte Corporation ($259.30) |
| 2021 | $3,668 | 135 | Seagen Inc. ($1,353) |
| 2020 | $2,496 | 129 | Astellas Pharma US Inc ($203.93) |
| 2019 | $1,918 | 117 | Merck Sharp & Dohme Corporation ($205.65) |
| 2018 | $2,189 | 108 | Novartis Pharmaceuticals Corporation ($331.67) |
| 2017 | $692.43 | 39 | Novartis Pharmaceuticals Corporation ($132.62) |
All Payment Transactions
928 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Genentech USA, Inc. | Alecensa (Biological), Itovebi, Phesgo | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: BioOncology | ||||||
| 12/19/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/18/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $25.13 | General |
| Category: Hematology | ||||||
| 12/09/2024 | PFIZER INC. | BRAFTOVI (Drug), MEKTOVI | Education | In-kind items and services | $13.04 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TALVEY (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $34.18 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| Category: Hematology | ||||||
| 11/12/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $8.22 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: Oncology | ||||||
| 10/30/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 1,983 | 49,670 | $1.3M | $338,512 |
| 2022 | 41 | 1,890 | 46,323 | $1.1M | $320,973 |
| 2021 | 37 | 1,943 | 65,478 | $1.0M | $321,736 |
| 2020 | 37 | 1,711 | 77,707 | $966,714 | $271,166 |
Total Patients
7,527
Total Services
239,178
Medicare Billing
$1.3M
Procedure Codes
156
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 288 | 1,075 | $172,000 | $98,766 | 57.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 3,300 | $122,400 | $61,004 | 49.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 35 | 315 | $204,750 | $29,424 | 14.4% |
| 99424 | Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | Office | 2023 | 144 | 462 | $52,020 | $27,389 | 52.7% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 19 | 27,000 | $135,000 | $23,250 | 17.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 12 | 96 | $96,000 | $12,727 | 13.3% |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 2023 | 28 | 131 | $15,065 | $9,369 | 62.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 231 | 883 | $57,395 | $9,124 | 15.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 248 | 1,036 | $31,080 | $8,679 | 27.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 238 | 1,007 | $45,315 | $7,651 | 16.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $11,515 | $5,665 | 49.2% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 17 | 113 | $39,550 | $5,243 | 13.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 38 | $8,550 | $4,668 | 54.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 48 | 102 | $17,340 | $4,455 | 25.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 28 | 197 | $18,715 | $4,148 | 22.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $6,200 | $3,244 | 52.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 28 | 43 | $6,880 | $3,080 | 44.8% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 23 | 101 | $7,070 | $1,877 | 26.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 29 | 113 | $11,300 | $1,860 | 16.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 157 | $6,280 | $1,672 | 26.6% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 70 | $12,250 | $1,436 | 11.7% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 17 | 82 | $16,400 | $1,396 | 8.5% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 20 | 208 | $62,400 | $1,360 | 2.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 13 | 63 | $7,245 | $1,135 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 18 | $2,070 | $1,080 | 52.2% |
About Dr. Andrew Johnson, M.D
Dr. Andrew Johnson, M.D is a Medical Oncology healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2011. The National Provider Identifier (NPI) number assigned to this provider is 1497045553.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Johnson, M.D has received a total of $21,882 in payments from pharmaceutical and medical device companies, with $3,998 received in 2024. These payments were reported across 928 transactions from 79 companies. The most common payment nature is "Food and Beverage" ($16,984).
As a Medicare-enrolled provider, Johnson has provided services to 7,527 Medicare beneficiaries, totaling 239,178 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Hematology
- Location Gainesville, GA
- Active Since 04/11/2011
- Last Updated 04/12/2021
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1497045553
Products in Payments
- ENHERTU (Biological) $2,063
- KISQALI (Drug) $1,339
- TUKYSA (Drug) $1,279
- KEYTRUDA (Biological) $1,140
- IMBRUVICA (Drug) $729.61
- OPDIVO (Biological) $524.01
- ADCETRIS (Biological) $463.11
- Lenvima (Drug) $430.16
- Enhertu (Drug) $427.65
- REBLOZYL (Biological) $419.61
- JAKAFI (Drug) $396.15
- LIBTAYO (Biological) $370.89
- MEKINIST (Drug) $317.91
- IBRANCE (Drug) $277.79
- IMFINZI (Drug) $269.54
- XTANDI (Drug) $253.11
- Cabometyx (Drug) $229.32
- ZEPZELCA (Drug) $212.58
- SOLIRIS (Drug) $191.66
- LYNPARZA (Drug) $191.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Gainesville
Dr. George Kim, M.d, M.D
Medical Oncology — Payments: $1.0M
Medical Oncology $1.0M
Dr. John Wingard, Md, MD
Medical Oncology — Payments: $147,953
Medical Oncology $147,953
Dr. Coy Heldermon, Md, MD
Medical Oncology — Payments: $47,064
Medical Oncology $47,064
Christopher Cogle, Md, MD
Medical Oncology — Payments: $33,817
Medical Oncology $33,817
Richard Locicero, M.d, M.D
Medical Oncology — Payments: $12,834
Medical Oncology $12,834
Devi Sampat, Md, MD
Medical Oncology — Payments: $10,292
Medical Oncology $10,292